Asset Details
Do you wish to reserve the book?
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Do you wish to request the book?
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Emerging Targets in Type 2 Diabetes and Diabetic Complications
2021
Overview
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
Type 2 diabetes is a complex metabolic disorder associated with a plethora of complications in peripheral organs. This review article highlights the novel targets that might play role in pathogenesis of type 2 diabetes. Further research on these targets might eventually pave the way to novel therapies for the treatment–or even the prevention–of type 2 diabetes.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
Subject
/ Diabetes
/ Diabetes Complications - drug therapy
/ Diabetes Complications - physiopathology
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetes Mellitus, Type 2 - physiopathology
/ Glucagon
/ Glucose
/ Humans
/ Hypoglycemic Agents - therapeutic use
/ Lipids
/ Liver
/ Pancreas
/ Proteins
/ Retina
/ Review
/ Reviews
